Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed Aug 18, 2022
- Accession no.
- 0001209191-22-046541
- Filed
- Aug 18, 2022, 8:22 AM ET
- Trade date
- Aug 17, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions. Open-market purchases total $507.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +9,984 | $2.52 | +$25,109.76 | 196,966,678 | Indirect | |
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +9,316 | $2.52 | +$23,476.32 | 196,975,994 | Indirect | |
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +35,374 | $2.53 | +$89,319.35 | 197,011,368 | Indirect | |
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +10,199 | $2.53 | +$25,803.47 | 197,021,567 | Indirect | |
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +36,770 | $2.54 | +$93,211.95 | 197,058,337 | Indirect | |
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +15,557 | $2.54 | +$39,514.78 | 197,073,894 | Indirect | |
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +25,796 | $2.55 | +$65,650.82 | 197,099,690 | Indirect | |
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +4 | $2.55 | +$10.2 | 197,099,694 | Indirect | |
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +13,539 | $2.56 | +$34,592.15 | 197,113,233 | Indirect | |
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +43,461 | $2.56 | +$111,260.16 | 197,156,694 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.